Cs10br05    (DrugBank: -)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
17多系統萎縮症1

17. 多系統萎縮症 [臨床試験数:107,薬物数:153(DrugBank:48),標的遺伝子数:59,標的パスウェイ数:104
Searched query = "Multiple system atrophy", "MSA-C", "MSA-P", "Olivopontocerebellar atrophy", "OPCA", "Striatonigral degeneration", "Shy-Drager syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 107 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03265444
(ClinicalTrials.gov)
April 13, 20186/8/2017Safety and Tolerability of CS10BR05 Inj. in Subjects With Multiple System AtrophyA Phase 1 Study to Evaluate the Safety and Tolerability of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Subjects With Multiple System AtrophyMultiple System AtrophyBiological: CS10BR05Corestem, Inc.NULLCompleted30 Years75 YearsAll9Phase 1Korea, Republic of